Zhengyang Hao

机构：Xizang Minzu University

发表论文 12 篇 · 总被引 147 次 · h-index 6

代表论文

• OTUB1 alleviates NASH through inhibition of the TRAF6‐ASK1 signaling pathways (2021 · Hepatology · 被引 42)
• E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING (2022 · Cell Death and Disease · 被引 34)
• Runt‐related transcription factor 1 (Runx1) aggravates pathological cardiac hypertrophy by promoting p53 expression (2021 · Journal of Cellular and Molecular Medicine · 被引 25)
• Dapagliflozin and Empagliflozin in Heart Failure with Reduced Ejection Fraction: A Retrospective Study (2022 · International Journal of General Medicine · 被引 13)
• Different Doses of Empagliflozin in Patients with Heart Failure with Reduced Ejection Fraction (2022 · International Heart Journal · 被引 10)
• Myotubularin‐Related Protein14 Prevents Neointima Formation and Vascular Smooth Muscle Cell Proliferation by Inhibiting Polo‐Like Kinase1 (2022 · Journal of the American Heart Association · 被引 6)